Elephas Biosciences Corporation

About Elephas Biosciences Corporation

Elephas Biosciences aims to revolutionize cancer treatment by predicting immunotherapy response using their innovative Elephas Live™ Platform. The company focuses on closing the gap in determining effective immunotherapy for cancer patients through advanced technology and live tumor tissue analysis.

Products & Services

Elephas Live™ Platform:A platform designed to predict immunotherapy response in solid tumors using fresh tumor biopsies. It involves three steps: Prepare (preserving tumor microenvironment), Assess (evaluating viability and response via advanced imaging), and Result (providing data for therapy selection through a secure cloud portal).

Specialties

Immunotherapy Response Prediction Live Tumor Tissue Analysis Advanced Imaging Technology Cancer Treatment Innovation

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Series B-2 T: - FT: Series B-2	A: 40000000 MR: - FA: 40 million FAN: 40000000	D: 2025-11-06 FD: 2025-11-06	6 investors
2	RT: Series C T: - FT: Series C	A: 55000000 MR: - FA: 55 million FAN: 55000000	D: 2024-01-23 FD: 2024-01-23	8 investors

Series B-2 Latest

2025-11-06

$40.0M

6 investors (Pro only)

Series C 2024-01-23

$55.0M

View 1 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

M

Maneesh K. Arora

Founder and Chief Executive Officer

H

Hinco J. Gierman

Chief Scientific Officer

C

Carolyn Morgan

Chief Commercial Officer

T

Terry Brady

Chief Financial Officer

M

Mike Szulczewski

Executive Vice President of Technology

A

Ann Leonard

Vice President of Quality & Regulatory

View 17 more team members with Pro

Unlock Full Team Directory

Recent News